Aim:The oxidized low-density lipoprotein(OxLDL) plays an important role in atherosclerosis yet it remains unclear if it damages circulating erythrocytes. Method: In this study。
Monocyte chemoattractant protein-1(MCP-1), a potent chemoattractant, is thought to play an important role in migration of monocytes into atherosclerotic lesions. The present study was designed to investigate the capac...Monocyte chemoattractant protein-1(MCP-1), a potent chemoattractant, is thought to play an important role in migration of monocytes into atherosclerotic lesions. The present study was designed to investigate the capacity of human peripheral blood monocytes to express MCP-1 and effects of native very low density lipoprotein (VLDL) and oxidized VLDL(OX-VLDL) on the expression. The total RNA was extracted from cultured monocytes, which were exposed to VLDL and OX-VLDL, and the media conditioned by monocytes were collected. MCP-1 mRNA expression was examined by Northern blot analysis. MCP-1 protein in conditioned media was determined by using sandwich ELISA. The results showed that monocytes can express MCP-1 after a 24 h incubation at 37℃，and the expression was markedly increased by a exposure to OX-VLDL, whereas the expression was slightly increased when exposed to VLDL. It suggests that the capacity of monocytes to produce MCP-1 that recruits and activates circulating monocytes may be of considerable importance in atherogenesis, and oxidation of VLDL enhances its potential to promote atherogenesis.展开更多
Objective:To research the anti-inflammatory and antioxidation effect of atorvastatin and probucol joint therapy on patients with acute coronary syndrome.Methods:228 patients with acute coronary syndrome were enrolled ...Objective:To research the anti-inflammatory and antioxidation effect of atorvastatin and probucol joint therapy on patients with acute coronary syndrome.Methods:228 patients with acute coronary syndrome were enrolled and randomized to atorvastatin group(atorvastatin 10 mg/d,n=120)and joint therapy group(atorvastatin 10 mg/d and probucol 0.25 g,2/d,n=108).The serum total cholesterol,low density lipoprotein cholesterol,hs-CRP and oxLDL level were measured before and 1 month after the therapy.Results:The indexes were no difference between the two groups before the therapy but significant difference 1 month after the therapy.Conclusion:Compare with atorvastatin alone,the joint therapy with probucol can give better anti-inflammatory and antioxidation effect and than better prognosis.展开更多
基金supported by National Natural Science Foundation of China(NSFC10572159)supported by "111 Project" entitled "Biomechanics&Tissue Repair Engineering"(No.:B06023)Chongqing Science&Technology Council(CSTC 2006ba5010)
文摘Aim:The oxidized low-density lipoprotein(OxLDL) plays an important role in atherosclerosis yet it remains unclear if it damages circulating erythrocytes. Method: In this study。
文摘Monocyte chemoattractant protein-1(MCP-1), a potent chemoattractant, is thought to play an important role in migration of monocytes into atherosclerotic lesions. The present study was designed to investigate the capacity of human peripheral blood monocytes to express MCP-1 and effects of native very low density lipoprotein (VLDL) and oxidized VLDL(OX-VLDL) on the expression. The total RNA was extracted from cultured monocytes, which were exposed to VLDL and OX-VLDL, and the media conditioned by monocytes were collected. MCP-1 mRNA expression was examined by Northern blot analysis. MCP-1 protein in conditioned media was determined by using sandwich ELISA. The results showed that monocytes can express MCP-1 after a 24 h incubation at 37℃，and the expression was markedly increased by a exposure to OX-VLDL, whereas the expression was slightly increased when exposed to VLDL. It suggests that the capacity of monocytes to produce MCP-1 that recruits and activates circulating monocytes may be of considerable importance in atherogenesis, and oxidation of VLDL enhances its potential to promote atherogenesis.
文摘Objective:To research the anti-inflammatory and antioxidation effect of atorvastatin and probucol joint therapy on patients with acute coronary syndrome.Methods:228 patients with acute coronary syndrome were enrolled and randomized to atorvastatin group(atorvastatin 10 mg/d,n=120)and joint therapy group(atorvastatin 10 mg/d and probucol 0.25 g,2/d,n=108).The serum total cholesterol,low density lipoprotein cholesterol,hs-CRP and oxLDL level were measured before and 1 month after the therapy.Results:The indexes were no difference between the two groups before the therapy but significant difference 1 month after the therapy.Conclusion:Compare with atorvastatin alone,the joint therapy with probucol can give better anti-inflammatory and antioxidation effect and than better prognosis.
